Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon-Michael Beasley

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Toxicology|May 7, 2025
Elucidating the mechanistic relationships between peroxisome proliferator-activated receptors and hepatic fibrosis using the ROBOKOP knowledge graphKaramarie Fecho, Nyssa Tucker, Jon-Michael Beasley, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Breaking the Phalanx: Overcoming Bacterial Drug Resistance with Quorum Sensing Inhibitors that Enhance Therapeutic Activity of AntibioticsJon-Michael Beasley, Dorjbal Dorjsuren, Sankalp Jain, et al.
Drug Discovery Today|September 26, 2025
Challenges of broad-spectrum antiviral drug discovery and development for emerging pathogensHolli-Joi Martin, Jon-Michael Beasley, Enes Kelestemur, et al.
Scientific Reports|June 2, 2026
The ROBOKOP v1.0 knowledge graph system for exploring relationships between biomedical entitiesKaramarie Fecho, Evan Morris, Jon-Michael Beasley, et al.
Journal of Medicinal Chemistry|April 3, 2024
Pharmacokinetics Profiler (PhaKinPro): Model Development, Validation, and Implementation as a Web Tool for Triaging Compounds with Undesired Pharmacokinetics ProfilesMarielle Rath, James Wellnitz, Holli-Joi Martin, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Toxicology|May 7, 2025
Elucidating the mechanistic relationships between peroxisome proliferator-activated receptors and hepatic fibrosis using the ROBOKOP knowledge graphKaramarie Fecho, Nyssa Tucker, Jon-Michael Beasley, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Breaking the Phalanx: Overcoming Bacterial Drug Resistance with Quorum Sensing Inhibitors that Enhance Therapeutic Activity of AntibioticsJon-Michael Beasley, Dorjbal Dorjsuren, Sankalp Jain, et al.
Drug Discovery Today|September 26, 2025
Challenges of broad-spectrum antiviral drug discovery and development for emerging pathogensHolli-Joi Martin, Jon-Michael Beasley, Enes Kelestemur, et al.
Scientific Reports|June 2, 2026
The ROBOKOP v1.0 knowledge graph system for exploring relationships between biomedical entitiesKaramarie Fecho, Evan Morris, Jon-Michael Beasley, et al.
Journal of Medicinal Chemistry|April 3, 2024
Pharmacokinetics Profiler (PhaKinPro): Model Development, Validation, and Implementation as a Web Tool for Triaging Compounds with Undesired Pharmacokinetics ProfilesMarielle Rath, James Wellnitz, Holli-Joi Martin, et al.
Pageof 1